HLBBF (H. Lundbeck AS) Receivables Turnover : 1.32 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. H. Lundbeck AS's Revenue for the three months ended in Sep. 2024 was $852 Mil. H. Lundbeck AS's average Accounts Receivable for the three months ended in Sep. 2024 was $647 Mil. Hence, H. Lundbeck AS's Receivables Turnover for the three months ended in Sep. 2024 was 1.32.

H. Lundbeck AS Receivables Turnover Historical Data

The historical data trend for H. Lundbeck AS's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Receivables Turnover Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

6.20

6.97

6.26

6.84

7.11

H. Lundbeck AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Receivables Turnover	Get a 7-Day Free Trial															1.19	1.44	1.49	1.25	1.32

Competitive Comparison of H. Lundbeck AS's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H. Lundbeck AS's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Receivables Turnover falls into.

H. Lundbeck AS Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

H. Lundbeck AS's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	2913.326	/ (	(385.738	+	433.809)	/	2 )
=	2913.326	/	409.7735
=	7.11

H. Lundbeck AS's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

	Receivables Turnover (Q: Sep. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Sep. 2024 ))	/	count )
=	851.742	/ (	(650.023	+	643.346)	/	2 )
=	851.742	/	646.6845
=	1.32

H. Lundbeck AS (OTCPK:HLBBF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

H. Lundbeck AS Receivables Turnover Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OTCPK:HLBBF) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

HLUBF:USA HLUNBc:UK 0ABR:UK 0ND5:UK HLUN A:Denmark HLUN B:Denmark LDBB:Germany LUNB:Austria

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.